LSD could be approved for anxiety in the US in 2027
The psychedelic drug LSD eased anxiety in a late-stage trial, paving the way for a probable approval in the US within the next two years
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.